Immunization is one of the most cost-effective public health interventions in history. Backed by extensive global and local data, the impact of vaccines on healthcare systems and populations is clear ...

Doctors reveal what they look for when examining a patient's longevity and how you can adopt the behaviors for yourself.

GSK has reported new clinical data pointing to a benefit with its respiratory syncytial virus (RSV) vaccine Arexvy when used to treat a younger age group than the over-60s for whom it is approved.